Literature DB >> 7676926

Survival rate and ultrastructure of vitrified bovine in vitro and in vivo developed embryos.

U Darvelid1, H Gustafsson, M Shamsuddin, B Larsson, H Rodriguez Martinez.   

Abstract

The capacity of different vitrification media and methods was tested onto in vivo and in vitro produced bovine morula/blastocysts and their ultrastructure and survival studied post-thawing. Two vitrification solutions were finally selected, named 40 ES (40% ethylene glycol in PBS containing 0.5 M sucrose) and 35 EFS (composed of 35% (v/v) ethylene glycol in PBS containing 0.5 M/l sucrose and 30% (w/v) Ficoll 70). The straws were either precooled or not precooled in nitrogen vapour, plunged and stored in LN2 for 10-25 days, and then thawed in a 20 degrees C waterbath. The content of the straws was rediluted in 1M sucrose solution in PBS and later cocultured with BOEC for 48 h. The overall survival rates for in vitro and in vivo embryos were 36% (12 of 33) and 20% (3 of 15) after 24 h and 21% (7 of 33) and 33% (5 of 15) after 48 h. The survival rates for precooled embryos were significantly higher than for not precooled (48% vs 13% after 24 h and 44% vs 4% after 48 h) when tested across vitrification media. The in vitro-produced embryos presented an ultrastructure similar to the pre-freeze state, irrespective of the vitrification media used. The in vivo developed embryos showed a rather modified post-thaw ultrastructure, with clear signs of osmotic changes at both the trophoblastic and embryonic cells. The results indicated that in vitro and in vivo developed bovine embryos can survive vitrification using ethylene glycol as a cryoprotectant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7676926      PMCID: PMC8101427     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  12 in total

1.  Vitrification of bovine embryos in a mixture of ethylene glycol and dimethyl sulfoxide.

Authors:  H Ishimori; K Saeki; M Inai; Y Nagao; J Itasaka; Y Miki; N Seike; H Kainuma
Journal:  Theriogenology       Date:  1993-08       Impact factor: 2.740

2.  Analysis of cryoprotectant, cooling rate and in situ dilution using conventional freezing or vitrification for cryopreserving sheep embryos.

Authors:  M C Schiewe; W F Rall; L D Stuart; D E Wildt
Journal:  Theriogenology       Date:  1991-08       Impact factor: 2.740

3.  In vitro development up to hatching of bovine in vitro-matured and fertilized oocytes with or without support from somatic cells.

Authors:  M Shamsuddin; B Larsson; H Gustafsson; H Rodriguez-Martinez
Journal:  Theriogenology       Date:  1993-05       Impact factor: 2.740

4.  Bovine embryo morphology and evaluation.

Authors:  G M Lindner; R W Wright
Journal:  Theriogenology       Date:  1983-10       Impact factor: 2.740

5.  A serum-free, cell-free culture system for development of bovine one-cell embryos up to blastocyst stage with improved viability.

Authors:  M Shamsuddin; B Larsson; H Gustafsson; H Rodriguez-Martinez
Journal:  Theriogenology       Date:  1994       Impact factor: 2.740

6.  Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification.

Authors:  W F Rall; G M Fahy
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

7.  Structural changes associated with freezing of bovine embryos.

Authors:  L R Mohr; A O Trounson
Journal:  Biol Reprod       Date:  1981-12       Impact factor: 4.285

8.  Successful vitrification of bovine blastocysts, derived by in vitro maturation and fertilization.

Authors:  S Tachikawa; T Otoi; S Kondo; T Machida; M Kasai
Journal:  Mol Reprod Dev       Date:  1993-03       Impact factor: 2.609

9.  Vitrification of bovine blastocysts obtained by in vitro culture of oocytes matured and fertilized in vitro.

Authors:  M Kuwayama; S Hamano; T Nagai
Journal:  J Reprod Fertil       Date:  1992-09

10.  Capacitation of bovine sperm by heparin.

Authors:  J J Parrish; J Susko-Parrish; M A Winer; N L First
Journal:  Biol Reprod       Date:  1988-06       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.